Skip to main content

Liver, Non-resectable, (RESIN) Registry

Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study

Overview

Overview

This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The information generated will help doctors better understand treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes for patients, as well as guide future research for using Y90 therapy, especially for those conditions where data is currently very limited or lacking.

Key Inclusion Criteria

Key Inclusion Criteria

For a patient to be eligible for participation in this study, all of the following criteria must apply.

  • Patients receiving SIR-Spheres therapy to the liver for the first time
  • Provision of written informed consent
  • Age 18 and older
Key Exclusion Criteria

Key Exclusion Criteria

A patient will not be eligible for participation in this study if any of the following criteria apply.

  • Prior completion of Y90 therapy to the liver (SIR-Spheres, TheraSpheres, or any other liver-targeted therapy involving the use of radiation-emitting spheres).
  • Patients who have received Y90 treatment in the past and who are returning for another Y90 treatment are ineligible, even if new areas are being targeted.
  • Need for surrogate consent. Patients unable to consent on their own behalves are not eligible for this study.
    Learn More

    Learn More

    To learn more, visit ClinicalTrials.Gov

    Study Type

    Phase: N/A

    Principal Investigator(s)

    Kyran Dowling, MD

    Sponsor(s)

    Sirtex Medical, Inc.